Photoactivatable (alternatively, photoremovable, photoreleasable, or photocleavable)
protecting groups (PPGs), also known as caged or photocaged compounds, are used to …

Cancer is rapidly becoming the top killer in the world. Most of the FDA approved anticancer
drugs are organic molecules, while metallodrugs are very scarce. The advent of the first …

Ruthenium (II)[Ru (II)] polypyridyl complexes have been the focus of intense investigations
since work began exploring their supramolecular interactions with DNA. In recent years …

Breast cancer is the most common cancer among women and is typically managed through
surgery, radiation therapy, and chemotherapy. However, chemotherapy drugs often lack …

History shows that metal-based drugs and remedies have been known and used since very
ancient times. For example, silver was employed in the treatment of wounds and ulcers …

Multidisciplinary research at the forefront of the field of hybrid materials has paved the way to
the development of endless examples of smart devices. One appealing concept in this fertile …

Photoactivated chemotherapy is an approach where a biologically active compound is
protected against interaction with the cell environment by a light-cleavable protecting group …

To achieve on‐demand drug release, mesoporous silica nanocarriers as antitumor platforms
generally need to be gated with stimuli‐responsive capping agents. Herein, a “smart” …

In vivo monitoring of the biodistribution and activation of prodrugs is urgently required. Near
infrared (NIR) fluorescence-active fluorophores with excellent photostability are preferable …

Ruthenium (II) and iridium (III) coordination compounds display excellent structural,
photophysical, and biological properties which make them highly promising as anticancer …